|
|
Previous Article | Table of Contents | Next Article 
Classification of Fanconi anemia patients by complementation analysis:
evidence for a fifth genetic subtype
H Joenje, JR Lo ten Foe, AB Oostra, CG van Berkel, MA Rooimans, T Schroeder- Kurth, RD Wegner, JJ Gille, M Buchwald and F Arwert
Department of Human Genetics, Free University, Amsterdam, The Netherlands.
Fanconi anemia (FA) is an autosomal recessive disease with diverse clinical
symptoms, life-threatening progressive panmyelopathy, and cellular
hypersensitivity to cross-linking agents. Currently, 4 genetic subtypes or
complementation groups (FA-A through FA-D) have been distinguished among 7
unrelated FA patients. We report the use of genetically marked FA
lymphoblastoid cell lines representing each of the 4 presently known
complementation groups to classify 13 unrelated FA patients through cell
fusion and complementation analysis. Twelve cell lines failed to complement
cross-linker sensitivity in fusion hybrids with only 1 of the 4 reference
cell lines and could thus be unambiguously classified as FA-A (7 patients),
FA-C (4 patients), or FA- D (1 patient). One cell line complemented all 4
reference cell lines and therefore represents a new complementation group,
designated FA-E. These results imply that at least 5 genes appear to be
involved in a pathway that, when defective, causes bone marrow failure in
FA patients.
Volume 86,
Issue 6,
pp. 2156-2160,
09/15/1995
Copyright © 1995 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. L. Medhurst, E. H. Laghmani, J. Steltenpool, M. Ferrer, C. Fontaine, J. de Groot, M. A. Rooimans, R. J. Scheper, A. R. Meetei, W. Wang, et al.
Evidence for subcomplexes in the Fanconi anemia pathway
Blood,
September 15, 2006;
108(6):
2072 - 2080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Leveille, E. Blom, A. L. Medhurst, P. Bier, E. H. Laghmani, M. Johnson, M. A. Rooimans, A. Sobeck, Q. Waisfisz, F. Arwert, et al.
The Fanconi Anemia Gene Product FANCF Is a Flexible Adaptor Protein
J. Biol. Chem.,
September 17, 2004;
279(38):
39421 - 39430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Levitus, M. A. Rooimans, J. Steltenpool, N. F. C. Cool, A. B. Oostra, C. G. Mathew, M. E. Hoatlin, Q. Waisfisz, F. Arwert, J. P. de Winter, et al.
Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes
Blood,
April 1, 2004;
103(7):
2498 - 2503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ikeda, M. Matsushita, Q. Waisfisz, A. Kinoshita, A. B. Oostra, A. W. M. Nieuwint, J. P. de Winter, M. E. Hoatlin, Y. Kawai, M. S. Sasaki, et al.
Genetic Reversion in an Acute Myelogenous Leukemia Cell Line from a Fanconi Anemia Patient with Biallelic Mutations in BRCA2
Cancer Res.,
May 15, 2003;
63(10):
2688 - 2694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yagasaki, D. Adachi, T. Oda, I. Garcia-Higuera, N. Tetteh, A. D. D'Andrea, M. Futaki, S. Asano, and T. Yamashita
A cytoplasmic serine protein kinase binds and may regulate the Fanconi anemia protein FANCA
Blood,
December 15, 2001;
98(13):
3650 - 3657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yang, Y. Kuang, R. M. De Oca, T. Hays, L. Moreau, N. Lu, B. Seed, and A. D. D'Andrea
Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9
Blood,
December 1, 2001;
98(12):
3435 - 3440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Otsuki, Y. Furukawa, K. Ikeda, H. Endo, T. Yamashita, A. Shinohara, A. Iwamatsu, K. Ozawa, and J. M. Liu
Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex
Hum. Mol. Genet.,
November 1, 2001;
10(23):
2651 - 2660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Rathbun, T. A. Christianson, G. R. Faulkner, G. Jones, W. Keeble, M. O'Dwyer, and G. C. Bagby
Interferon-gamma -induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members
Blood,
December 15, 2000;
96(13):
4204 - 4211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Kumaresan and M. W. Lambert
Fanconi anemia, complementation group A, cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links
Carcinogenesis,
April 1, 2000;
21(4):
741 - 751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Brois, L. W. McMahon, N. I. Ramos, L. M. Anglin, C. E. Walsh, and M. W. Lambert
A deficiency in a 230 kDa DNA repair protein in Fanconi anemia complementation group A cells is corrected by the FANCA cDNA
Carcinogenesis,
September 1, 1999;
20(9):
1845 - 1853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Waisfisz, J. P. de Winter, F. A. E. Kruyt, J. de Groot, L. van der Weel, L. M. Dijkmans, Y. Zhi, F. Arwert, R. J. Scheper, H. Youssoufian, et al.
A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA
PNAS,
August 31, 1999;
96(18):
10320 - 10325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Li, C. A. Peterson, X. Lu, P. Wei, and R. J. Legerski
Interstrand Cross-Links Induce DNA Synthesis in Damaged and Undamaged Plasmids in Mammalian Cell Extracts
Mol. Cell. Biol.,
August 1, 1999;
19(8):
5619 - 5630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Garcia-Higuera, Y. Kuang, D. Naf, J. Wasik, and A. D. D'Andrea
Fanconi Anemia Proteins FANCA, FANCC, and FANCG/XRCC9 Interact in a Functional Nuclear Complex
Mol. Cell. Biol.,
July 1, 1999;
19(7):
4866 - 4873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yamashita, G. M. Kupfer, D. Naf, A. Suliman, H. Joenje, S. Asano, and A. D. D'Andrea
The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation
PNAS,
October 27, 1998;
95(22):
13085 - 13090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Näf, G. M. Kupfer, A. Suliman, K. Lambert, and A. D. D'Andrea
Functional Activity of the Fanconi Anemia Protein FAA Requires FAC Binding and Nuclear Localization
Mol. Cell. Biol.,
October 1, 1998;
18(10):
5952 - 5960.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Hoshino, J. Wang, M. P. Devetten, N. Iwata, S. Kajigaya, R. J. Wise, J. M. Liu, and H. Youssoufian
Molecular Chaperone GRP94 Binds to the Fanconi Anemia Group C Protein and Regulates Its Intracellular Expression
Blood,
June 1, 1998;
91(11):
4379 - 4386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Hoatlin, T. A. Christianson, W. W. Keeble, A. T. Hammond, Y. Zhi, M. C. Heinrich, P. A. Tower, and G. C. Bagby Jr
The Fanconi Anemia Group C Gene Product Is Located in Both the Nucleus and Cytoplasm of Human Cells
Blood,
February 15, 1998;
91(4):
1418 - 1425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Heinrich, M. E. Hoatlin, A. J. Zigler, K. V. Silvey, A. C. Bakke, W. W. Keeble, Y. Zhi, C. A. Reifsteck, M. Grompe, M. G. Brown, et al.
DNA Cross-Linker-Induced G2/M Arrest in Group C Fanconi Anemia Lymphoblasts Reflects Normal Checkpoint Function
Blood,
January 1, 1998;
91(1):
275 - 287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Levran, T. Erlich, N. Magdalena, J. J. Gregory, S. D. Batish, P. C. Verlander, and A. D. Auerbach
Sequence variation in the Fanconi anemia gene FAA
PNAS,
November 25, 1997;
94(24):
13051 - 13056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A.E. Kruyt, Q. Waisfisz, L. M. Dijkmans, M. A.J.A. Hermsen, H. Youssoufian, F. Arwert, and H. Joenje
Cytoplasmic Localization of a Functionally Active Fanconi Anemia Group A-Green Fluorescent Protein Chimera in Human 293 Cells
Blood,
November 1, 1997;
90(9):
3288 - 3295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-L. Fu, J. R. L. T. Foe, H. Joenje, K. W. Rao, J. M. Liu, and C. E. Walsh
Functional Correction of Fanconi Anemia Group A Hematopoietic Cells by Retroviral Gene Transfer
Blood,
November 1, 1997;
90(9):
3296 - 3303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Thyagarajan and C. Campbell
Elevated Homologous Recombination Activity in Fanconi Anemia Fibroblasts
J. Biol. Chem.,
September 12, 1997;
272(37):
23328 - 23333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. D'Andrea and M. Grompe
Molecular Biology of Fanconi Anemia: Implications for Diagnosis and Therapy
Blood,
September 1, 1997;
90(5):
1725 - 1736.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Rathbun, G. R. Faulkner, M. H. Ostroski, T. A. Christianson, G. Hughes, G. Jones, R. Cahn, R. Maziarz, G. Royle, W. Keeble, et al.
Inactivation of the Fanconi Anemia Group C Gene Augments Interferon-gamma -Induced Apoptotic Responses in Hematopoietic Cells
Blood,
August 1, 1997;
90(3):
974 - 985.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Kupfer, T. Yamashita, D. Naf, A. Suliman, S. Asano, and A. D. D'Andrea
The Fanconi Anemia Polypeptide, FAC, Binds to the Cyclin-Dependent Kinase, cdc2
Blood,
August 1, 1997;
90(3):
1047 - 1054.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Gillio, P. C. Verlander, S.D. Batish, P.F. Giampietro, and A. D. Auerbach
Phenotypic Consequences of Mutations in the Fanconi Anemia FAC Gene: An International Fanconi Anemia Registry Study
Blood,
July 1, 1997;
90(1):
105 - 110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Freedman
Congenital Marrow Failure Syndromes and Malignant Hematopoietic Transformation
Oncologist,
December 1, 1996;
1(6):
354 - 360.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|